Jarnagin WR - Search Results

1

Response to the Comment on "Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in Aninternational Cohort".

Zheng J, Chapman WC, Turcotte S, Koerkamp BG, Lee SY, Jarnagin WR. Zheng J, et al. Among authors: jarnagin wr. Ann Surg. 2019 Mar;269(3):e34-e35. doi: 10.1097/SLA.0000000000002871. Ann Surg. 2019. PMID: 30724808 No abstract available.

2

Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model.

Jarnagin WR, Delman K, Kooby D, Mastorides S, Zager J, Brennan MF, Blumgart LH, Federoff H, Fong Y. Jarnagin WR, et al. Ann Surg. 2000 May;231(5):762-71. doi: 10.1097/00000658-200005000-00017. Ann Surg. 2000. PMID: 10767798 Free PMC article.

3

Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation.

Cha CH, Ruo L, Fong Y, Jarnagin WR, Shia J, Blumgart LH, DeMatteo RP. Cha CH, et al. Among authors: jarnagin wr. Ann Surg. 2003 Sep;238(3):315-21; discussion 321-3. doi: 10.1097/01.sla.0000086548.84705.ef. Ann Surg. 2003. PMID: 14501497 Free PMC article.

4

Predictors and patterns of recurrence after resection of hepatocellular carcinoma.

Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo RP. Cha C, et al. Among authors: jarnagin wr. J Am Coll Surg. 2003 Nov;197(5):753-8. doi: 10.1016/j.jamcollsurg.2003.07.003. J Am Coll Surg. 2003. PMID: 14585409

5

Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy.

Grobmyer SR, Wang L, Gonen M, Fong Y, Klimstra D, D'Angelica M, DeMatteo RP, Schwartz L, Blumgart LH, Jarnagin WR. Grobmyer SR, et al. Among authors: jarnagin wr. Ann Surg. 2006 Aug;244(2):260-4. doi: 10.1097/01.sla.0000217606.59625.9d. Ann Surg. 2006. PMID: 16858189 Free PMC article.

6

The impact of margins on outcome after hepatic resection for colorectal metastasis.

Are C, Gonen M, Zazzali K, Dematteo RP, Jarnagin WR, Fong Y, Blumgart LH, D'Angelica M. Are C, et al. Among authors: jarnagin wr. Ann Surg. 2007 Aug;246(2):295-300. doi: 10.1097/SLA.0b013e31811ea962. Ann Surg. 2007. PMID: 17667509 Free PMC article.

7

Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients.

Gold JS, Are C, Kornprat P, Jarnagin WR, Gönen M, Fong Y, DeMatteo RP, Blumgart LH, D'Angelica M. Gold JS, et al. Among authors: jarnagin wr. Ann Surg. 2008 Jan;247(1):109-17. doi: 10.1097/SLA.0b013e3181557e47. Ann Surg. 2008. PMID: 18156930

8

Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer.

Ito H, Are C, Gonen M, D'Angelica M, Dematteo RP, Kemeny NE, Fong Y, Blumgart LH, Jarnagin WR. Ito H, et al. Among authors: jarnagin wr. Ann Surg. 2008 Jun;247(6):994-1002. doi: 10.1097/SLA.0b013e31816c405f. Ann Surg. 2008. PMID: 18520227

9

Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.

Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, Dematteo RP. Katz SC, et al. Among authors: jarnagin wr. Ann Surg. 2009 Apr;249(4):617-23. doi: 10.1097/SLA.0b013e31819ed22f. Ann Surg. 2009. PMID: 19300227

10

Randomized clinical trials in hepatocellular carcinoma.

Yopp AC, Jarnagin WR. Yopp AC, et al. Among authors: jarnagin wr. Surg Oncol Clin N Am. 2010 Jan;19(1):151-62. doi: 10.1016/j.soc.2009.09.012. Surg Oncol Clin N Am. 2010. PMID: 19914564 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

573 results

Search Page

Filters